Skip to main content
. 2013 Aug 9;3(1):80–85. doi: 10.1007/s13730-013-0090-1

Table 2.

Time course of laboratory results and corresponding clinical conditions

Date 5 June 14 June 21 June 18 July 19 July 24 July
Condition 1st admission 2nd admission After DEX (1 mg) After DEX (8 mg)
K (mEq/L) 2.1 2.9 4.2 3.7
ACTH (pg/mL) 66.2 53 89.9 66.2
Cortisol (μg/dL) 45.7 28.5 39 40 24.3 13
UFC (μg/day)
TTKG 8.26
K suppl. (mEq/day) 0 48 72 72 72 72
Date 31 July 28 Aug. 3 Sept. 5 Sept. 10 Oct. 25 Oct.
Condition CRH test 3rd admission CSS CSS CRH test
K (mEq/L) 4.6 2.1 4.4 3.4
ACTH (pg/mL) 34.1 119.4 40.3 36.2 75.7 60.1
Cortisol (μg/dL) 20.3 42.1 12 18.8 31.2 28.9
UFC (μg/day) 275 >457.2 849.4
TTKG 12.9 9.89 7.4
K suppl. (mEq/day) 72 72 72 24 48 24
Date 31 Oct. 2 Nov. 9 Nov. 14 Nov. 25 Jan.
Condition 2 days after metyrapone
K (mEq/L) 5.2 5.1 4.8 3.9
ACTH (pg/mL) 18.4 42.3 52.6 26.6 18
Cortisol (μg/dL) 9.1 29.5 31.3 5.6 0.9
UFC (μg/day) 41.3
TTKG 6.39
K suppl. (mEq/day) 24 24 24 0 0

UFC urinary free cortisol of 24 h, DEX dexamethasone test, suppl. supplementation, TTKG transtubular potassium gradient